Nomura Asset Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.43M | Buy |
25,645
+4,343
| +20% | +$750K | 0.01% | 613 |
|
|
2025
Q1 | $3.32M | Buy |
21,302
+796
| +4% | +$124K | 0.01% | 655 |
|
|
2024
Q4 | $2.82M | Buy |
20,506
+2,506
| +14% | +$345K | 0.01% | 689 |
|
|
2024
Q3 | $2.69M | Buy |
18,000
+5,371
| +43% | +$802K | 0.01% | 699 |
|
|
2024
Q2 | $1.72M | Sell |
12,629
-1,300
| -9% | -$177K | 0.01% | 732 |
|
|
2024
Q1 | $2.11M | Buy |
13,929
+1,261
| +10% | +$191K | 0.01% | 712 |
|
|
2023
Q4 | $1.6M | Hold |
12,668
| – | – | 0.01% | 740 |
|
|
2023
Q3 | $1.19M | Sell |
12,668
-1,744
| -12% | -$163K | 0.01% | 783 |
|
|
2023
Q2 | $1.29M | Buy |
14,412
+1,094
| +8% | +$97.6K | 0.01% | 777 |
|
|
2023
Q1 | $1.43M | Buy |
13,318
+648
| +5% | +$69.5K | 0.01% | 759 |
|
|
2022
Q4 | $1.55M | Hold |
12,670
| – | – | 0.01% | 744 |
|
|
2022
Q3 | $1.31M | Hold |
12,670
| – | – | 0.01% | 749 |
|
|
2022
Q2 | $1.18M | Buy |
12,670
+890
| +8% | +$82.7K | 0.01% | 795 |
|
|
2022
Q1 | $1.38M | Buy |
11,780
+1,140
| +11% | +$134K | 0.01% | 797 |
|
|
2021
Q4 | $1.43M | Buy |
10,640
+1,622
| +18% | +$218K | 0.01% | 809 |
|
|
2021
Q3 | $1.44M | Buy |
9,018
+896
| +11% | +$143K | 0.01% | 779 |
|
|
2021
Q2 | $1.07M | Hold |
8,122
| – | – | 0.01% | 846 |
|
|
2021
Q1 | $1.05M | Buy |
+8,122
| New | +$1.05M | 0.01% | 828 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 973 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 946 |
|